The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Crossref DOI link: https://doi.org/10.1007/s40265-017-0717-1
Published Online: 2017-03-04
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Declerck, Paul
Danesi, Romano
Petersel, Danielle
Jacobs, Ira
Funding for this research was provided by:
Pfizer
License valid from 2017-03-04